News

Multiple myeloma is a cancer of the plasma cells in which abnormal plasma cells multiply uncontrollably in the bone marrow and occasionally in other parts of the body. It is the second most common ...
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...
Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...
Bone health expert Debi Robinson joined Gayle Guyardo, host of the globally syndicated health and wellness show Bloom, to ...
A drug called levothyroxine, the second-most-commonly prescribed medication among older U.S. adults, has been linked to a ...
Dad felt like he was ‘walking in flippers’ before incurable cancer diagnosis - Mart Roe’s symptoms were initially dismissed ...
The denosumab biosimilars Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) are now available in the US.